UK MHRA expects “high volume” side effects (ADR) but “vaccine” is “safe and efficient”
The UK urgently provisioned outside EU procurement standards for £1.5M an AI software to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs). As we are being told there were no corners cut in assessing the safety of Pfizer experimental vials (“vaccine”) and people’s health is paramount, the European Federation of Pharmaceutical…